Mitchell P. Kopin 13D and 13G filings for Virpax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-23 4:06 pm Purchase |
2024-05-14 | 13G | Virpax Pharmaceuticals, Inc. VRPX |
Mitchell P. Kopin | 4,429 4.990% |
4,429 (New Position) |
Filing |